#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant peritoneal neoplasm Parkinson's disease Immunodeficiency Henoch-Schonlein purpura Iron overload Stargardt's disease Lennox-Gastaut syndrome Deafness Myotonia Breast angiosarcoma metastatic Cholangiosarcoma Chronic granulomatous disease Oesophageal adenocarcinoma Bone marrow disorder Optic glioma More trials…

    Learn about Rare Diseases

    Richter’s syndrome – Basic Information Encephalitis autoimmune – Life with Disease Mantle cell lymphoma stage III – Basic Information Congenital nephrogenic diabetes insipidus Breast angiosarcoma metastatic – Life with Disease Proteus syndrome – Basic Information Antithrombin III deficiency – Basic Information Cytokine release syndrome – Diagnostics Lennox-Gastaut syndrome – Treatment Krabbe’s disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Deutivacaftor 99MTC-EUK-(SO3)CY5-MAS3 ADCE-D01 Nazartinib RO7284755 ZOLPIDEM TARTRATE Zongertinib Munc-T3 ALXN2420 LTI-03 Cd19-Car_Lenti_Allo Ficlatuzumab Sapablursen Cefuroxime Sodium Metronidazole Caplacizumab Emtricitabine Teriflunomide Clindamycin Phosphate Human Serum Albumin 5% More therapies…

    Learn about Your Condition

    Glomerulonephritis acute Suicidal ideation Pancreatic carcinoma recurrent Tardive dyskinesia Pertussis Ureteric cancer Ophthalmoplegia Adrenal insufficiency Adenomyosis Lupus nephritis Naevoid melanoma Hypertension Bladder cancer Venous thrombosis limb Cystic fibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Omalizumab monotherapy for patients with vegetable (plant‑based food) allergy due to LTP and profilin sensitization

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Food allergy
    Investigated Drugs:
    • Omalizumab
    Spain

  • Testing How Well Mepivacaine Works to Reduce Pain During Arterial Puncture in Patients with Respiratory Disease Needing Blood Gas Analysis

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Mepivacaine Hydrochloride
    • Sodium Chloride
    Spain

  • Diagnostic Accuracy of 68Ga‑FAPI‑46 PET/CT in Patients with Suspected Giant Cell Arteritis and Polymyalgia Rheumatica

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    The Netherlands

  • Study on Stem Cell Treatment for Venous Ulcers in the Legs Using Bioengineered Artificial Mesenchymal Sheet (BAMS)

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Skin ulcer
    Investigated Drugs:
    • Allogenic Adipose-Derived Adult Mesenchymal Stem Cells Expanded On Fibrin-Hyaluronic Biological Matrix
    Spain

  • Study on Treating Chronic Anal Fissure in Patients Using Ultrasound-Guided Injections of Botulinum Toxin A

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    Spain

  • Study on Reducing Postoperative Pain in Breast Surgery Patients Using Lidocaine Hydrochloride Injection

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Lidocaine Hydrochloride
    Spain
Previous Page
1 … 908 909 910 911 912 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!